Antidepressant Drugs Market Size to Grow by USD 5.22 Bn, Driven by Rising Prevalence of Depression - Technavio

NEW YORK, Nov. 1, 2022 /PRNewswire/ -- The antidepressant drugs market has grown substantially over the years. To estimate the size of the market, Technavio has tracked the recent trends and developments in the market. The analysts at Technavio have considered various aspects such as the consumer base, adoption rate, average selling price, revenue generated by vendors, and various other factors to estimate the market size. Download Sample PDF Report Here to get an idea of the overall scope of the full report.

The report on the antidepressant drugs market by Technavio expects the market size to increase at a CAGR of 5.44% and register an incremental growth of USD 5.22 billion between 2021 and 2026. However, the growth forecast could be missed due to factors such as social stigma associated with depression and lack of awareness among people.

Get lifetime access to our Technavio Insights! Subscribe to our Basic Plan billed annually at USD 5000

According to Technavio, the growth of the market is primarily driven by the rising prevalence of depression. The number of depression cases has increased significantly since 2021 due to the negative impact of the COVID-19 pandemic on mental health. According to a Lancet study, 76 million additional cases of anxiety disorders and 53 million cases of MDD were recorded in 2020. Thus, the increasing number of cases of anxiety disorder will drive market growth during the forecast period.

"Alliances and collaborations and awareness programs for depression will further accelerate the growth of the market", according to an analyst at Technavio.

The antidepressant drugs market is fragmented due to the presence of numerous vendors. The vendors are deploying organic and inorganic growth strategies to compete in the market. Vendors are focusing on the development of drugs to tap into the huge unmet need. As drug development is cost-intensive, the market is expected to witness collaborations and acquisitions. This, in turn, will fuel the growth of the market during the forecast period.

This report provides a full list of key vendors, their strategies, and the latest developments. Buy Now for detailed vendor information

The report breaks down the market into the following segments:

• Disease type: Major compulsive disorder, obsessive compulsive disorder, and others
• Geography: North America, Europe, Asia, and Rest of World (ROW)

Based on disease type, the major compulsive disorder segment is expected to create more revenue in the market. Major compulsive disorder is diagnosed when a person has a persistently low or depressed mood, anhedonia or decreased interest in pleasurable activities, and others.

In terms of region, North America will emerge as the dominant region, occupying 37% of the global market share. The regional market is driven by government initiatives to combat depression.

The complete report on the global antidepressant drugs market offers detailed insights into the potential business segments and regions to invest in over the forecast period. Before making the purchase, we recommend reading our Sample PDF Report.

The antidepressant drugs market report answers questions such as:

• Is the market structure fragmented or concentrated?
• What was the market size in 2021 and the forecast for the antidepressant drugs market through 2026?
• Which are the best product segment areas to invest in over the forecast period?
• What is the market share of dominant and strong vendors in the antidepressant drugs market?
• What are the inhibiting factors and the impact of COVID-19 on the antidepressant drugs market growth?
• What are the latest trends and regulatory frameworks in the antidepressant drugs market?

Got more queries? Speak to our analyst now

Users who bought this report also purchased the following:

• Migraine Drugs Market by End-user, Type, and Geography - Forecast and Analysis 2022-2026: This report extensively covers segmentation by end-user (hospitals, retail, and online), type (preventive and abortive), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). 37% of the market's growth will originate from North America during the forecast period. The market share growth in the hospital segment will be significant.
• Narcolepsy Drugs Market by Type and Geography - Forecast and Analysis 2022-2026: This report extensively covers segmentation by type (narcolepsy with cataplexy, narcolepsy without cataplexy, and secondary narcolepsy) and geography (North America, Europe, Asia, and Rest of World (ROW)). 44% of the market's growth will originate from North America during the forecast period. The market share growth by the narcolepsy with cataplexy segment will be significant.

Browse Health Care Market Reports

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Disease Type
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026 
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary 
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

• 4.2 Bargaining power of buyers 
• Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers 
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants 
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes 
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry 
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition 
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Disease Type

• 5.1 Market segments 
• Exhibit 24: Chart on Disease Type - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Disease Type - Market share 2021-2026 (%)

• 5.2 Comparison by Disease Type 
• Exhibit 26: Chart on Comparison by Disease Type
• Exhibit 27: Data Table on Comparison by Disease Type

• 5.3 Major depressive disorder - Market size and forecast 2021-2026 
• Exhibit 28: Chart on Major depressive disorder - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Major depressive disorder - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Major depressive disorder - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Major depressive disorder - Year-over-year growth 2021-2026 (%)

• 5.4 Obsessive compulsive disorder - Market size and forecast 2021-2026 
• Exhibit 32: Chart on Obsessive compulsive disorder - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Obsessive compulsive disorder - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Obsessive compulsive disorder - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Obsessive compulsive disorder - Year-over-year growth 2021-2026 (%)

• 5.5 Others - Market size and forecast 2021-2026
• Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)

• 5.6 Market opportunity by Disease Type 
• Exhibit 40: Market opportunity by Disease Type ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview 
• Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation 
• Exhibit 42: Chart on Market share by geography 2021-2026 (%)
• Exhibit 43: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison 
• Exhibit 44: Chart on Geographic comparison
• Exhibit 45: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026
• Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 Greece - Market size and forecast 2021-2026
• Exhibit 66: Chart on Greece - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on Greece - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on Greece - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Greece - Year-over-year growth 2021-2026 (%)

• 7.9 China - Market size and forecast 2021-2026
• Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)

• 7.10 Canada - Market size and forecast 2021-2026
• Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)

• 7.11 India - Market size and forecast 2021-2026
• Exhibit 78: Chart on India - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on India - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on India - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on India - Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography 
• Exhibit 82: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges 
• Exhibit 83: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape 
• Exhibit 84: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption 
• Exhibit 85: Overview on factors of disruption

• 9.4 Industry risks 
• Exhibit 86: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered 
• Exhibit 87: Vendors covered

• 10.2 Market positioning of vendors 
• Exhibit 88: Matrix on vendor position and classification

• 10.3 AbbVie Inc. 
• Exhibit 89: AbbVie Inc. - Overview
• Exhibit 90: AbbVie Inc. - Product / Service
• Exhibit 91: AbbVie Inc. - Key offerings

• 10.4 Alkermes Public Ltd. Co. 
• Exhibit 92: Alkermes Public Ltd. Co. - Overview
• Exhibit 93: Alkermes Public Ltd. Co. - Product / Service
• Exhibit 94: Alkermes Public Ltd. Co. - Key news
• Exhibit 95: Alkermes Public Ltd. Co. - Key offerings

• 10.5 Bausch Health Companies Inc. 
• Exhibit 96: Bausch Health Companies Inc. - Overview
• Exhibit 97: Bausch Health Companies Inc. - Business segments
• Exhibit 98: Bausch Health Companies Inc. - Key news
• Exhibit 99: Bausch Health Companies Inc. - Key offerings
• Exhibit 100: Bausch Health Companies Inc. - Segment focus

• 10.6 Eli Lilly and Co. 
• Exhibit 101: Eli Lilly and Co. - Overview
• Exhibit 102: Eli Lilly and Co. - Product / Service
• Exhibit 103: Eli Lilly and Co. - Key offerings

• 10.7 F. Hoffmann La Roche Ltd. 
• Exhibit 104: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 105: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 106: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 107: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 108: F. Hoffmann La Roche Ltd. - Segment focus

• 10.8 H Lundbeck AS 
• Exhibit 109: H Lundbeck AS - Overview
• Exhibit 110: H Lundbeck AS - Product / Service
• Exhibit 111: H Lundbeck AS - Key offerings

• 10.9 Johnson and Johnson 
• Exhibit 112: Johnson and Johnson - Overview
• Exhibit 113: Johnson and Johnson - Business segments
• Exhibit 114: Johnson and Johnson - Key news
• Exhibit 115: Johnson and Johnson - Key offerings
• Exhibit 116: Johnson and Johnson - Segment focus

• 10.10 Lupin Ltd. 
• Exhibit 117: Lupin Ltd. - Overview
• Exhibit 118: Lupin Ltd. - Product / Service
• Exhibit 119: Lupin Ltd. - Key news
• Exhibit 120: Lupin Ltd. - Key offerings

• 10.11 MagVenture AS 
• Exhibit 121: MagVenture AS - Overview
• Exhibit 122: MagVenture AS - Product / Service
• Exhibit 123: MagVenture AS - Key offerings

• 10.12 Viatris Inc. 
• Exhibit 124: Viatris Inc. - Overview
• Exhibit 125: Viatris Inc. - Business segments
• Exhibit 126: Viatris Inc. - Key offerings
• Exhibit 127: Viatris Inc. - Segment focus

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist 
• Exhibit 128: Inclusions checklist
• Exhibit 129: Exclusions checklist

• 11.3 Currency conversion rates for US$ 
• Exhibit 130: Currency conversion rates for US$

• 11.4 Research methodology 
• Exhibit 131: Research methodology
• Exhibit 132: Validation techniques employed for market sizing
• Exhibit 133: Information sources

• 11.5 List of abbreviations 
• Exhibit 134: List of abbreviations

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED